https://oncosynergy.com/ 2024-11-05T19:08:49+00:00 1.00 https://oncosynergy.com/clinical-trials/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/science/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/sab/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/news/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/our-mission/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/our-team/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/glioblastoma/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/contact/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/fundraisers/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/homepage-2020/privacy-terms-of-use/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/study-leads-to-orphan-drug-status-for-acute-myeloid-leukemia/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/oncosynergy-announces-first-patient-treated-in-first-in-human-clinical-trial-of-os2966-in-recurrent-glioblastoma/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/oncosynergy-launches-phase-i-trial-for-patients-with-recurrent-glioblastoma/ 2024-11-05T19:08:49+00:00 0.80 https://oncosynergy.com/category/news/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/author/onco_staff/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-receivves-300k-sttr-grant-to-develop-novel-oncolytic-virus/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/fda-acceptance-of-ind-application-for-phase-i-trial-of-os2966-in-patients-with-recurrent-glioblastoma/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/author/onco_admin/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-announces-submission-of-ind-application-for-os2966-in-the-treatment-of-glioblastoma/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-raises-series-a-round/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-and-infuseon-therapeutics-partner-to-combat-glioblastoma/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-appoints-oncology-drug-development-veteran-jean-pierre-bizzari-md-to-scientific-advisory-board/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/fda-grants-second-orphan-designation-for-os2966/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/category/uncategorized/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/os-and-cmc-partner-to-combat-ebola/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/orphan-drug-designation-obtained-for-os2966/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/emerging-company-profile-in-biocentury-the-bernstein-report/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-and-cmc-biologics-enter-into-agreement-for-os2966-program/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/world-federation-of-neuro-oncology-meeting/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/oncosynergy-highlighted-in-startup-portraits/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/martin-karplus-awarded-the-2013-nobel-prize/ 2024-11-05T19:08:49+00:00 0.64 https://oncosynergy.com/wp-content/uploads/2019/02/16125039-PreviewRelease.pdf 2021-10-26T22:33:52+00:00 0.51 https://oncosynergy.com/category/news/page/2/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2024/05/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2021/04/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2020/11/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2020/01/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2019/04/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2019/02/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2018/05/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2017/06/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2016/05/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2015/03/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2014/12/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2014/08/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2014/06/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2013/12/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2013/11/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/2013/10/ 2024-11-05T19:08:49+00:00 0.51 https://oncosynergy.com/author/onco_admin/page/2/ 2024-11-05T19:08:49+00:00 0.51